Hemopure Addresses the Serious Threat Posed to Blood Supplies by the Emerging Infectious Diseases

While blood transfusion will always be the gold standard of treatment, there is an obvious need for alternative products, such as Hemopure, in the US healthcare system and emergency preparedness.

SOUDERTON, PA - March 26, 2020 /MarketersMedia/ —

Ensuring a regular and quality blood supply is a constant challenge for healthcare systems worldwide. In the US, according to data from the American Red Cross, a mere 3% of citizens normally donate blood even though 38% of the population are eligible to donate; Every two seconds, someone requires a transfusion; And a single donation could save as many as three lives. The current US blood supplies can barely meet the needs of patients, many of whom rely on transfusions to survive, either because of severe trauma, life-threatening medical conditions, or surgical complications. In times of national emergencies, such as pandemics or major natural disasters, the lack of sufficient supplies can lead to unnecessary loss of life, exacerbating already tragic situations. Hence, the strong advocacy from the medical and scientific communities for the development and use of blood substitutes, such as the oxygen-carrying solution Hemopure, manufactured by Hemoglobin Oxygen Therapeutics, a clinical-stage biotech company headquartered in Souderton, PA.

While clinicians have been able to use evidence-based medical and surgical concepts to optimize hemostasis and minimize blood loss in an effort to improve patient outcomes, the number of donors over the past few years has dropped significantly, more than negating any savings. An additional risk, this time to the safety of US blood supply, is that despite what officials describe as near-Herculean efforts to screen donated blood for the emerging viruses, the nation's blood supply is not immune from contaminations as was the case a few years ago when the CDC announced that several cases of West Nile illness were attributed to blood transfusions that contained tainted blood.

The push to develop alternatives to traditional blood transfusions has intensified in the 21st century amidst the global population growth and aging, the emergence of new infectious agents, and the seemingly rising number of natural disasters due to climate change. Not only is the number of donors insufficient to meet demand, but the nature of blood is such that it cannot be readily stockpiled, as refrigerated blood has a shelf-life of only 42 days. With multiple positive medical journal articles already published on Hemopure, its characteristics - including no blood typing or cross matching as well as three-year stability without the need for refrigeration - are ideal for out-of-hospital applications and stockpiling for national emergencies. It is no surprise then that the US Department of Defense is funding a large prehospital clinical trial to evaluate use of Hemopure as a resuscitation fluid in conjunction with freeze-dried plasma.

Currently, Hemopure is stocked and used at several hospitals as an investigational product, under FDA’s authorized expanded access protocols, for the treatment of severe anemia when blood transfusions are not an option. Interestingly, regulatory authorities in South Africa and Russia have already granted market approval for Hemopure for the treatment of perioperative anemia. “While blood transfusion will always be the gold standard of treatment, there is also an obvious need for alternative products, such as Hemopure, in our healthcare system and emergency preparedness,” experts at BloodSupplySolution.com assert. “Stakeholders in government, academic medicine and industry should find a way to work together to make this happen proactively rather than reactively.”

Blood Supply Solution – Oxygen-Carrying Blood Substitutes: http://bloodsupplysolution.com

Expanded Access Protocol Using HBOC-201 – ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT02684474

Contact Info:
Name: Gail Weiss
Email: Send Email
Organization: BloodSupplySolution.com
Phone: 267-871-9577
Website: http://bloodsupplysolution.com

Source URL: https://marketersmedia.com/hemopure-addresses-the-serious-threat-posed-to-blood-supplies-by-the-emerging-infectious-diseases/88951297

Source: MarketersMedia

Release ID: 88951297

Latest News

Innovative fashion designers lead the way on sustainability

Apr 6, 2020

LONDON — Innovative fashion designers are turning to such things as horseradish and nettles to make sustainable clothing and accessories to the delight of a growing number of buyers. While more consumers are paying closer attention to how the production of goods impacts the environment, old habits die hard. A buy-and-toss mentality persists despite a boost from celebrities helping to drive the upcycle and vintage movements. Actress Maggie Q, who created an activewear line from recycled fabrics, is among activists who see plenty of room for improvement. She says she feels "sick about fast fashion.'' "You hear people say, 'Well,...

Stocks rise on Wall Street as rally stretches to fourth day

Apr 6, 2020

NEW YORK — U.S. stocks rallied Monday, rising with European and several Asian markets following surprisingly strong reports on China's economy. Growth in factory activity and retail sales in the world's second-largest economy both beat analysts’ expectations for last month. That layered on top of optimism from last week’s long-awaited “Phase 1” trade deal between China and the United States, which removed some of the uncertainty that’s hung over businesses and investors. The interim trade deal is one of a “trifecta of positive catalysts” that swept through the market last week and could help support it through the end of...

Kentucky gov's race stirs clash over casino suicide claims

Apr 6, 2020

LOUISVILLE, Ky. — Entering the final days of Kentucky's bitter race for governor, Republican incumbent Matt Bevin exposed himself to a new attack by flatly denying his recorded claim that suicides happen nightly in casinos. Telling a debate audience Saturday night that the truth matters, Bevin challenged his opponent to produce a tape proving his denial wrong. Democrat Andy Beshear offered up the audiotape Sunday. The televised exchange turned Bevin's summer radio interview on WKDZ into a talking point for Democrats heading into the last full week of campaigning in the close gubernatorial contest. In the interview, Bevin claimed, without...

Companies reach tentative deal to settle opioids lawsuit

Apr 6, 2020

CLEVELAND — The nation's three dominant drug distributors and a big drugmaker have reached a tentative deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday, according to a lead lawyer for the local governments suing the drug industry. The tentative deal, details of which were to be announced later Monday, settles claims brought by the Ohio counties of Cuyahoga and Summit against distributors AmerisourceBergen, Cardinal Health and McKessen and the manufacturer Teva. After five drug manufacturers, including Johnson & Johnson, reached settlements leading up to...

Schumer calls for federal probe of contaminated baby food

Apr 6, 2020

NEW YORK — The Senate's top Democrat is calling on the Food and Drug Administration to examine a report that found dozens of baby food products contaminated with lead and other metals. Sen. Chuck Schumer says Sunday the FDA must take more action to regulate the baby food industry. A study by Healthy Babies Bright Futures found the presence of heavy metals in 95% of the 168 baby foods that were tested. The study found 95% of the food tested contained lead, arsenic, mercury or cadmium. It found one in four baby foods that were tested contained all four metals....

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!